HYDERABAD: Frequent inspections of Indian plants by the US FDA and subsequent observations slow down the growth of pharma exports even as US-China trade war presents huge opportunities for the drug industry, GV Prasad, Chairman, CII National Committee on Pharmaceuticals and Co-Chairman and MD ofDr Reddys Laboratories Ltd said on Monday. "It (effect of frequent inspections) is quite significant (on India pharma exports). "Everybody should up their game in terms of quality, systems, discipline, integrity of data. China as a nation is moving towards more innovation and getting out of what they perceive as low value-added business. That is the opportunity which is opening up for India.

Source: Economic Times November 18, 2019 11:37 UTC